SCHEMBL885315

SCHEMBL885315

O=C=C1CC=Cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ALDH1A1 P00352 2/20 0.36
IDO1 P14902 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
BCHE P06276 1/20 0.36
POLB P06746 1/20 0.36
PTPRC P08575 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
PTPN1 P18031 1/20 0.36
ACHE P22303 1/20 0.36
CES1 P23141 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27299209 0.80 CA1 (0.33) CA1CA2ALDH1A1IDO1HSD17B10
SCHEMBL28326264 0.78 ALDH1A1 (0.31) CA1CA2ALDH1A1HSD17B10MEN1
SCHEMBL27439415 0.74 APP (0.42) ALDH1A1HSD17B10KDM4EMEN1LMNA
SCHEMBL2319629 0.74 CA1 (0.30) CA1CA2
SCHEMBL249997 0.72 CES1 (0.45) CA1CA2ALDH1A1IDO1HSD17B10
SCHEMBL29385734 0.72 CES1 (0.45) CA1CA2ALDH1A1IDO1HSD17B10
SCHEMBL7214854 0.72 ALDH1A1 (0.38) CA1CA2ALDH1A1IDO1HSD17B10
SCHEMBL30862184 0.71 CES1 (0.43) CA1CA2ALDH1A1IDO1HSD17B10
SCHEMBL30676949 0.71 CES1 (0.43) CA1CA2ALDH1A1IDO1HSD17B10
Hydrochloric Acid SCHEMBL2710070 0.71 MEN1 (0.43) CA1CA2ALDH1A1IDO1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148537-B2 Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA A/S (DK) 2012-04-03 US claimed
EP-2125736-B1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA AS (DK) 2011-03-30 EP claimed
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA (DK) 2010-02-11 US claimed
CN-101611005-A Be used as the acetophenones of the replacement of PDE4 inhibitor LEO PHARMA AS (DK) 2009-12-23 CN claimed
EP-2125736-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS Leo Pharma A/S (DK) 2009-12-02 EP claimed
WO-2008077404-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA A/S (DK) 2008-07-03 WO claimed
CN-106414391-B Method by making aromatic systems Direct Electrochemistry amination that is unactivated or deactivating on boron-doped diamond anode to prepare 1,5- diaminonaphthalene and 1- amino -5- nitronaphthalene 科思创德国股份有限公司 2019-08-30 CN disclosed
CN-110023277-A Compound, resin, composition and corrosion-resisting pattern forming method and circuit pattern forming method 三菱瓦斯化学株式会社 2019-07-16 CN disclosed
CN-109942637-A Metal complex, organic electroluminescence device 北京诚志永华显示科技有限公司 2019-06-28 CN disclosed
CN-109715592-A Compound, resin, composition and pattern forming method 三菱瓦斯化学株式会社 2019-05-03 CN disclosed
CN-109476576-A Compound, resin, composition, resist pattern forming method, and circuit pattern forming method 三菱瓦斯化学株式会社 2019-03-15 CN disclosed
CN-109476575-A Compound, resin, composition and corrosion-resisting pattern forming method and circuit pattern forming method 三菱瓦斯化学株式会社 2019-03-15 CN disclosed
CN-106414391-A Method for producing 1.5-diaminonaphthalene and 1-amino-5-nitronaphthalene by direct electrochemical amination of non-activated or deactivated aromatic systems on boron-doped diamond anodes 科思创德国股份有限公司 2017-02-15 CN disclosed
CN-1217940-C Naphthol derivatives UENO SEIYAKU OYO KENKYUJO KK (JP) 2005-09-07 CN disclosed
CN-1616592-A White light-emitting compound, process for producing the same, and luminescent element utilizing the same HIROSE ENGINEERING CO LTD (JP) 2005-05-18 CN disclosed
CN-1401631-A Bis (amino carbonylnaphthol) derivs. AGANO PHARMACEUTICAL APPLIC I (JP) 2003-03-12 CN disclosed
CN-1098316-C Bisazo compounds and process for the preparation thereof UENO SEIYAKU OYO KENKYUJO KK (JP) 2003-01-08 CN disclosed
CN-1386120-A Naphthol derivatives UENO SEIYAKU OYO KENKYUJO KK (JP) 2002-12-18 CN disclosed
CN-1090205-C Condensed ring azo compound, process for producing the same and use thereof UENO SEIYAKU OYO KENKYUJO KK (JP) 2002-09-04 CN disclosed
CN-1226911-A Condensed ring azo compound and process for producing the same UENO SEIYAKU OYO KENKYUJO KK (JP) 1999-08-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS PDE4A, PDE4B, PDE3B CA1 1828/4885CA2 364/4885ALDH1A1 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.